Bioinformatics Analysis Reveals Ki-67 Specific microRNA Functions in Pediatric Embryonal Tumors

Pediatric Central Nervous System (CNS) neoplasms are the second most prevalent tumors of childhood. CNS malignancies are considered as the most notorious type of tumors, due to their anatomic position manifesting an imminent threat to the patients’ life. miRNAs are molecules that play a significant role in CNS tumor biology. At the same time diagnostic markers such as Ki-67 have played an important role in CNS tumor diagnosis. In a previous study we have identified several miRNAs, common to different subtypes of pediatric embryonal CNS malignancies as well as, we have identified miRNAs that manifest significant dynamics with respect to their expression and the neoplasmatic subtype. Among the previously reported miRNAs, several have manifested significant differences with respect to Ki-67 expression. Those miRNAs, were further analyzed bioinformatically and related functions were revealed, where some of them confirmed Ki-67 role as a proliferation marker but also predicted novel miRNAs functions in pediatric embryonal tumors.

[1]  Martina Kitanova,et al.  Correlation Between Ki-67 Index, World Health Organization Grade and Patient Survival in Glial Tumors With Astrocytic Differentiation , 2017, Cureus.

[2]  Johannes Gerdes,et al.  The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.

[3]  G. Lambrou,et al.  Can obesity-induced inflammation in skeletal muscle and intramuscular adipose tissue accurately detect liver fibrosis? , 2018, Journal of musculoskeletal & neuronal interactions.

[4]  Georgios Papachristoudis,et al.  Human microRNA target analysis and gene ontology clustering by GOmir, a novel stand-alone application , 2009, BMC Bioinformatics.

[5]  F. Tzortzatou-Stathopoulou,et al.  miR-15a and miR-24-1 as putative prognostic microRNA signatures for pediatric pilocytic astrocytomas and ependymomas , 2016, Tumor Biology.

[6]  P. Dong,et al.  MiR-137 and miR-34a directly target Snail and inhibit EMT, invasion and sphere-forming ability of ovarian cancer cells , 2016, Journal of experimental & clinical cancer research : CR.

[7]  F. Kayaselçuk,et al.  PCNA and Ki-67 in Central Nervous System Tumors: Correlation with the Histological Type and Grade , 2002, Journal of Neuro-Oncology.

[8]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[9]  Artemis G. Hatzigeorgiou,et al.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..

[10]  F. Tzortzatou-Stathopoulou,et al.  Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms , 2014, Journal of Hematology & Oncology.

[11]  G. Dimitriadis,et al.  Inter-tissue expression patterns of the key metabolic biomarker PGC-1α in severely obese individuals: Implication in obesity-induced disease. , 2018, Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese.

[12]  Georgia D. Koutsouri,et al.  Bioinformatics and Regression Analyses Manifest Tumor-Specific miRNA Expression Dynamics in Pediatric Embryonal Malignancies , 2018, 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[13]  S. Powell,et al.  New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors. , 2007, Archives of pathology & laboratory medicine.

[14]  Christopher J. Cheng,et al.  miR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer. , 2016, Cancer research.

[15]  G. Lambrou,et al.  MicroRNA expression profiles in pediatric dysembryoplastic neuroepithelial tumors , 2016, Medical Oncology.

[16]  C. Lanvers-Kaminsky,et al.  Inhibitors of histone deacetylases as potential therapeutic tools for high‐risk embryonal tumors of the nervous system of childhood , 2007, International journal of cancer.

[17]  T. Jiang,et al.  Identifying Ki-67 specific miRNA–mRNA interactions in malignant astrocytomas , 2013, Neuroscience Letters.

[18]  Daljit Singh,et al.  Histological spectrum of ependymomas and correlation of p53 and Ki-67 expression with ependymoma grade and subtype. , 2004, Indian journal of cancer.

[19]  George I. Lambrou,et al.  Elucidating the identity of resistance mechanisms to prednisolone exposure in acute lymphoblastic leukemia cells through transcriptomic analysis: A computational approach , 2011, Journal of Clinical Bioinformatics.